6 Interstitial Lung Disease Clinical Trials in New Haven, CT (2026)

Q: How do I join a clinical trial in New Haven?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you.

Recruiting Interstitial Lung Disease Studies in New Haven

NCT01915511Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to inc...

New Haven, CT3,000 participantsDuke University

View Study Details

NCT06238622Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...

New Haven, CT1,700 participantsBoehringer Ingelheim

View Study Details

NCT06921993Recruiting

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

Pneumonia is a major cause of illness and death in children, with an annual incidence of about 3.3 per 1,000 in those under five years old, many requiring hospitalization. The diagnosis is challenging...

New Haven, CT659 participantsMeyer Children's Hospital IRCCS

View Study Details

NCT05919849Recruiting

Supporting Parents in Affirming Their Children's Experiences of Stigma

The purpose of this study is to develop and test two brief online writing interventions to improve parental acceptance of sexual and gender minority youth (SGMY) in the Southeast United States....

New Haven, CT129 participantsYale University

View Study Details

NCT06672549Recruiting

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesi...

New Haven, CT125 participantsEli Lilly and Company

View Study Details

NCT06968845Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Rationale: LTI-03 is an experimental medication breathed into the lungs using an inhaler. It is being studied for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is a progressive, fatal lung...

New Haven, CT120 participantsRein Therapeutics

View Study Details

About Interstitial Lung Disease Clinical Trials in New Haven

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 6 interstitial lung disease clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 5,733 participants. Research is being sponsored by Duke University, Boehringer Ingelheim, Meyer Children's Hospital IRCCS and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in New Haven — FAQ

Are there interstitial lung disease clinical trials in New Haven?

Yes, there are 6 interstitial lung disease clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 6 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov